Is JCR Pharmaceuticals Co., stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, JCR Pharmaceuticals Co., pays dividends. Last time was Sunday 1st of December 2024 where the investors holding the stock on Friday 27th of September 2024 were paid JPY10 per share. Over the last 32 times between 2007 and 2024, JCR Pharmaceuticals Co., has paid JPY336 with an average of JPY10.5 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for JCR Pharmaceuticals Co., 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was JPY1 952.50, you would have made a loss of JPY-1 287.50 per share or -65.94%
Yes, the average daily trading liquidity for JCR Pharmaceuticals Co., is JPY496 763 thousand. You should therefore be able to get in and out of your positions relatively fast.
JCR Pharmaceuticals Co., has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.19, the company's ability to pay off the debt is normal. JCR Pharmaceuticals Co., has a good net profit margin of 12.85% and should have high tolerances against inflation.
We have calculated the inflation risk for JCR Pharmaceuticals Co., to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.